A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome
- PMID: 11051354
- DOI: 10.1111/j.1572-0241.2000.03192.x
A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome
Abstract
Objective: The aim of this study was to estimate the prevalence of irritable bowel syndrome using different standard definitions (Rome and Manning criteria) and to determine the degree of agreement between these definitions.
Methods: A population-based, cross-sectional survey study was conducted by mailing a valid, reliable questionnaire to an age- and gender-stratified random sample of residents of Olmsted County, MN, aged 30-69 yr. The threshold for a positive diagnosis of irritable bowel was varied from two to four of the six Manning criteria and from two to three of the five defecation disorders in the Rome criteria. Unadjusted as well as age- and gender-adjusted prevalence rates were calculated for each of the five definitions of IBS. Percent agreement and kappa statistics were calculated to assess agreement between the definitions.
Results: Questionnaires were returned by 643 of 892 eligible subjects (72% response rate). The age- and gender-adjusted prevalence of IBS varied from 20.4% using a threshold of two symptoms in the Manning criteria to 8.5% using a threshold of three defecation disorders in the Rome criteria. The percent agreement for each comparison of Manning and Rome definitions was always >90%. The kappa values ranged from 0.55 to 0.78, with the best agreement occurring between a threshold of three symptoms of Manning and two defecation disorders in Rome.
Conclusions: The prevalence of IBS varied substantially depending on the specific definition of IBS used. The range of prevalence estimates in Olmsted County was similar to other published figures when IBS definition was accounted for. These findings are useful in interpreting epidemiological and clinical studies of IBS.
Comment in
-
Rome? Manning? Who cares?Am J Gastroenterol. 2000 Oct;95(10):2679-81. doi: 10.1111/j.1572-0241.2000.03171.x. Am J Gastroenterol. 2000. PMID: 11051333 No abstract available.
Similar articles
-
Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice?Am J Gastroenterol. 2000 Nov;95(11):3176-83. doi: 10.1111/j.1572-0241.2000.03197.x. Am J Gastroenterol. 2000. PMID: 11095338
-
[Differences in definitions of irritable bowel syndrome].Ugeskr Laeger. 2000 Mar 27;162(13):1877-81. Ugeskr Laeger. 2000. PMID: 10765694 Danish.
-
Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population.Aliment Pharmacol Ther. 2004 Aug 1;20(3):339-45. doi: 10.1111/j.1365-2036.2004.02034.x. Aliment Pharmacol Ther. 2004. PMID: 15274671
-
Applying case definition criteria to irritable bowel syndrome.Clin Med Res. 2008 May;6(1):9-16. doi: 10.3121/cmr.2008.788. Clin Med Res. 2008. PMID: 18591372 Free PMC article. Review.
-
Definition and classification of irritable bowel syndrome: current consensus and controversies.Gastroenterol Clin North Am. 2005 Jun;34(2):173-87. doi: 10.1016/j.gtc.2005.02.011. Gastroenterol Clin North Am. 2005. PMID: 15862928 Review.
Cited by
-
Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.Gut. 2007 Feb;56 Suppl 1(Suppl 1):1-113. doi: 10.1136/gut.2006.117598. Gut. 2007. PMID: 17303614 Free PMC article. Review. No abstract available.
-
The interface of psychiatry and irritable bowel syndrome.Curr Psychiatry Rep. 2004 Jun;6(3):210-5. doi: 10.1007/s11920-004-0066-0. Curr Psychiatry Rep. 2004. PMID: 15142474 Review.
-
Risk and Protective Factors Related to Early Adverse Life Events in Irritable Bowel Syndrome.J Clin Gastroenterol. 2020 Jan;54(1):63-69. doi: 10.1097/MCG.0000000000001153. J Clin Gastroenterol. 2020. PMID: 30575634 Free PMC article.
-
Effectiveness of mesalazine to treat irritable bowel syndrome: A meta-analysis.Medicine (Baltimore). 2019 Jul;98(28):e16297. doi: 10.1097/MD.0000000000016297. Medicine (Baltimore). 2019. PMID: 31305414 Free PMC article.
-
Prevalence and risk factors for abdominal bloating and visible distention: a population-based study.Gut. 2008 Jun;57(6):756-63. doi: 10.1136/gut.2007.142810. Gut. 2008. PMID: 18477677 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical